Research ReportMelatonin, minocycline and ascorbic acid reduce oxidative stress and viral titers and increase survival rate in experimental Venezuelan equine encephalitis
Introduction
Venezuelan equine encephalitis (VEE) virus produces an acute infection in human and murine central nervous system (CNS) with neuronal damage (Weaver, 1998, Schoneboom et al., 2000a, Schoneboom et al., 2000b). During an anti-viral immune response a balance between two opposing pathways is observed: the production of pro-inflammatory cytokines and cytotoxic cells to limit the viral infection and regulators to control the excessive immune response and avoid tissue damage. Nitric oxide (NO) can mediate immunopathology and/or inhibit the antiviral immune response to promote chronic infection (Burrack and Morrison, 2014). In this regard, NO has been implicated in the experimental spread of Venezuelan equine encephalitis (VEE) virus and other viruses (Bonilla et al., 2004, Perrone et al., 2013, Mannick, 1995). The increased presence of NO in VEE infection is probably due to the activation of induced nitric oxide synthase (iNOS) (Valero et al., 2006, Schoneboom et al., 2000a, Schoneboom et al., 2000b). Oxidative stress and/or altered immune response could be involved in VEE viral infection. In this regard, pro-oxidant and immune modulator properties of NO have been reported (Burrack and Morrison, 2014, Mannick, 1995); therefore, approaches to inhibit the effect of NO on viral replication and oxidative stress need to be used appropriated compounds. Melatonin (MTL), a molecule with antioxidant properties, has shown to have protective effects on experimental murine VEE virus infection (Bonilla et al., 2003, Bonilla et al., 2004, Valero et al., 2007, Valero et al., 2009). In addition to anti-oxidant properties, MLT has the capability to regulate leukocyte function and contributes to the control of inflammation in tissues acting as both an activator or inhibitor of the inflammatory and immune responses (Silvestre and Rossi, 2013). MLT also decreases the toll like receptor mediated downstream gene expression and the subsequent NFkB-dependent gene expression, such as those encoding for TNF-α and iNOS produced during viral replication, preventing injury through the inhibition of the oxidative stress and of the production of pro-inflammatory cytokines (Huang et al., 2008). Minocycline (MIN), a tetracycline derivative, and ascorbic acid (AA) have shown antiviral activities in cell cultures and animal model of infections by Japanese encephalitis, human immunodeficiency and measles viruses (Dutta et al., 2010a, Dutta et al., 2010b, Bhaskar et al., 2012, Mishra et al., 2009, Zink et al., 2005). Beside the capacity to inhibit iNOS (Garrido-Mesa et al., 2013), minocycline combines both immunomodulatory and anti-microbial properties that can be neuroprotector. It has also been shown that MIN reduces virus infection and immune responses in several experimental models. This anti-viral effect seems to be linked to its ability to reduce the activation of monocytes and their permissiveness to viral infection. Anti viral mechanisms of MIN include, decreased p38 activation and viral replication in lymphocytes (Zink et al., 2005), reduced production of MCP-1 altering chemotaxis (Zink et al., 2005), blunting changes in activation/proliferation markers and cytokine secretion necessary for the activation pathway that regulate viral replication, decreasing viral production by inhibition of DNA integration or transcription (Si et al., 2004, Zink et al., 2005, Follstaedt et al., 2008, Ratai et al., 2010, Szeto et al., 2010). Several mechanisms of action have been proposed for the potential beneficial effect on viral infections of AA. The anti-oxidative ability of ascorbate, reducing oxidative stress could be important in detoxification and neutralization of reactive oxygen species associated with infection (Wintergerst et al., 2006). AA is also necessary for neutrophil function (Wintergerst et al., 2006) and can stimulate the production of interferon and other anti-viral cytokines, down regulate inflammation, and reduce the ability of several virus to infect cultured cells (Bissell et al., 1980, White et al., 1986, Gerber, 1975, Mandl et al., 2009, Mikirova et al., 2012, Furuya et al., 2008). These data suggest a potential beneficial effect of these compounds in VEE virus infection. Therefore, the aim of the present study was to analyze the effect of MLT, MIN and AA on the viral replication, NO production and lipid peroxidation in the brain of VEE virus infected mice and in infected neuroblastoma cell cultures.
Section snippets
Effect of MLT, MIN or AA on the survival rate of VEE virus infected animals
MLT, MIN or AA was capable of decreasing the mortality rate of mice infected by VEE virus. Analysis of survival curves showed that 100% of mortality rate was reached earlier in untreated infected mice (day 7); time when, 50% of MLT, MIN or AA treated infected mice were alive and remained in this way until the end of experiment (day 10) (Fig. 1). Log rank test analysis showed significant differences when untreated animal curve were compared with treated animal curves (p=0.001). Uninfected
Discussion
The current study reports that murine brain VEE virus replication is reduced by MLT, MIN or AA. In addition to viral replication, VEE virus induced increased production of NO and MDA content in infected mouse brain, suggesting a relationship between VEE virus infection and oxidative stress. NO and MDA content were also reduced by MLT, MIN and AA. Since, treatments with these compounds were capable of reducing viral replication and oxidative stress an association between those two parameters is
VEE virus, viral titration and replication
Goajira strain VEEV (E-100) was used as challenge virus in all assays. Virus was isolated from the brain of a dead donkey (epidemic Venezuelan equine encephalitis, 1964, Goajira, Venezuela) and had one passage in suckling mouse brain cells and one passage in Vero cells. Vero cells (African green monkey kidney) were maintained in Eagle׳s MEM supplemented with 5% fetal bovine serum and 1% penicillin/streptomycin. Virus was titrated using the plaque assay in Vero cell cultures. Virus titers were
Disclosure statement
This manuscript has no conflict of interest.
Author contributions
NV, EB and JM conceived the study and designed the study protocol; JS and SA carried out the assays and cultures; NV, EB, JM and MAM analysis and interpretation of these data. NV and JM drafted the manuscript. All authors read and approved the final manuscript. NV and JM are guarantors of the paper.
Acknowledgments
This work was supported by Fondo de Investigación de la Seguridad Social (Spain), Consejería de Educación, Comunidad de Madrid, MITIC-CM (S-2010/BMD-2502), Instituto de Salud Carlos III, MEC (PIO51871, CIBERehd). Sponsor had no involvement in any aspect of manuscript preparation.
References (48)
- et al.
Inactivation of HSV-2 by ascorbate-Cu(II) and its protecting evaluation in CF-1 mice against encephalitis
J. Virol. Methods
(2004) - et al.
Minocycline differentially modulates macrophage mediated peripheral immune response following Japanese encephalitis virus infection
Immunobiology
(2010) - et al.
Ascorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by beta-amyloid
Brain Res.
(2006) Is minocycline useful for therapy of acute viral encephalitis?
Antiviral Res.
(2012)- et al.
In vitro inactivation of the rabies virus by ascorbic acid
Int. J. Infect. Dis.
(2004) The antiviral role of nitric oxide
Res. Immunol.
(1995)- et al.
Antioxidant potential of Minocycline in Japanese Encephalitis Virus infection in murine neuroblastoma cells: correlation with membrane fluidity and cell death
Neurochem. Int.
(2009) - et al.
Minocycline delays disease onset and mortality in reovirus encephalitis
Exp. Neurol.
(2005) - et al.
Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice
J. Neuroimmunol.
(2000) - et al.
Melatonin induces changes to serum cytokines in mice infected with the Venezuelan equine encephalomyelitis virus
Trans. R. Soc. Trop. Med. Hyg.
(2002)